PD-1 Inhibitor Therapy in a Patient with Preexisting P-ANCA Vasculitis: A Case Report and Review of the Literature

BACKGROUND: Recurrent endometrial cancer after definitive therapy is a lethal disease. Recently, immune checkpoint inhibitors (ICI) have improved the management of mismatch repair-deficient (MSI-H) endometrial cancer. Autoimmune side effects are known to occur with ICI. As a result, patients with pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Amanda, del Carmen, Marcela, Yeku, Oladapo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479461/
https://www.ncbi.nlm.nih.gov/pubmed/32934857
http://dx.doi.org/10.1155/2020/3428945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479461/
https://www.ncbi.nlm.nih.gov/pubmed/32934857
http://dx.doi.org/10.1155/2020/3428945

Ejemplares similares